<DOC>
	<DOCNO>NCT02044094</DOCNO>
	<brief_summary>This multiple-dose study non-treatment seek male female subject moderate severe opioid use disorder meet criterion Diagnostic Statistical Manual Mental Disorders , 5th Edition ( DSM-5 ) evaluate effectiveness RBP-6000 block exogenous opioids .</brief_summary>
	<brief_title>Multiple Dose Study Blockade Opioid Effects Injections Buprenorphine Participants With Opioid Disorder</brief_title>
	<detailed_description>A study RBP-6000 300 mg administer via subcutaneous depot injection use ATRIGEL Delivery System determine whether difference average score subjective-effects questionnaire complete study participant ( use visual analog scale ( VAS ) ) administer 6 mg 18 mg hydromorphone compare 0 mg hydromorphone ( placebo ) opioid blockade test ( challenge ) .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Hydromorphone</mesh_term>
	<mesh_term>Buprenorphine , Naloxone Drug Combination</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<criteria>Meet Diagnostic Statistical Manual Mental Disorders , 5th Edition ( DSM5 ) criteria moderate severe opioid use disorder screen seek opioid use disorder treatment Body mass index &gt; = 18.0 &lt; = 33.0 kg/m^2 Females woman childbearing potential ( defined woman surgically sterile postmenopausal least 1 year prior informed consent ) must negative pregnancy test prior enrollment must agree use medically acceptable mean contraception screen least 3 month last dose study drug Male subject female partner childbearing potential must agree use medically acceptable contraception screen least 3 month last dose study drug Subjects current diagnosis require chronic opioid treatment Subjects currently meet criterion diagnosis moderate severe substance use disorder DSM5 criterion substance opioids , caffeine , nicotine . Subjects abuse used buprenorphine within 14 day prior informed consent . Other protocoldefined criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Opioid dependent</keyword>
	<keyword>Buprenorphine</keyword>
	<keyword>Suboxone Film</keyword>
	<keyword>Opioid blockade</keyword>
	<keyword>Hydromorphone challenge</keyword>
</DOC>